Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Qaseem A, Barry M, Humphrey L, Forciea M, Fitterman N, Horwitch C, Kansagara D, McLean R, Wilt T. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 279-290. PMID: 28055075, DOI: 10.7326/m16-1860.Peer-Reviewed Original ResearchConceptsType 2 diabetesOral pharmacologic treatmentGlycemic controlPharmacologic treatmentPatient populationAmerican CollegeSodium-glucose cotransporter 2 inhibitorsType 2Clinical Practice Guideline UpdateDipeptidyl peptidase-4 inhibitorsCotransporter 2 inhibitorsSGLT-2 inhibitorsSystolic blood pressurePeptidase-4 inhibitorsDPP-4 inhibitorsTarget patient populationTotality of evidenceACP guidelinesCerebrovascular morbidityCause mortalityOral medicationsOral therapyPharmacologic therapyBlood pressureHemoglobin A1c